Classement en actions
#6984
Caregen Co., Ltd. is primarily involved in the creation and development of... Caregen Co., Ltd. is primarily involved in the creation and development of biomimetic peptides. The company operates through distinct business segments, each catering to specific markets. Its Professional Therapy division engineers medical devices utilizing functional peptides and sophisticated sustained-release technology. Through its Cosmeceutical line, Caregen offers a variety of products for skin and hair care, including solutions for whitening, anti-inflammatory purposes, and those mimicking botulinum toxin functions. The Health Functional Food division provides dietary supplements specifically designed for blood control. Additionally, the Raw Material segment supplies essential peptide growth factors. Founded on August 17, 2001, the firm is headquartered in Anyang-si, South Korea.
Capitalisation boursière
$1.78B
Changement (1 jour)
-1.13%
Échange Caregen Co., Ltd. (214370)
Le prix 214370 avec la capitalisation boursière de B
Capitalisation boursière de Caregen Co., Ltd.(214370)
Capitalisation boursière: $1.78B
En August 2026, Caregen Co., Ltd. a une capitalisation boursière de $1.78B. Cela fait de Caregen Co., Ltd. la 6984th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Caregen Co., Ltd. du 2015 au 2026
214370 par rapport au top 5 des plus populaires stocks
| Prix pour 214370 |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.532T
|
+311,090.93%
|
|
|
|
|
$4.608T
|
+259,141.28%
|
|
|
|
|
$4.096T
|
+230,307.67%
|
|
|
|
|
$3.748T
|
+210,774.84%
|
|
|
|
|
$2.761T
|
+155,245.39%
|
